Three-year clinical outcome in all-comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study

Eline H. Ploumen, Rosaly A. Buiten, Marlies M. Kok, Carine J.M. Doggen, K. Gert van Houwelingen, Martin G. Stoel, Frits H.A.F. de Man, Marc Hartmann, Paolo Zocca, Gerard C.M. Linssen, Cees J.A. Doelman, Gert D. Kant, Clemens von Birgelen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Downloads (Pure)

Fingerprint Dive into the research topics of 'Three-year clinical outcome in all-comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study'. Together they form a unique fingerprint.

Medicine & Life Sciences